Back

High frequency electrograms abolition as a valuable target for remap during ventricular tachycardia ablation. The HF REMAP study.

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Poster session (3): mechanisms and management of arrhythmias Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Daniele Valente

Campus Bio-Medico University Hospital, Rome (Italy)

196 More presentations in this session

Presentation thumbnail
Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects
Doctor J. Uutela (Jyvaskyla, FI)
Abstract
Presentation thumbnail
A wearable SCG-based approach for early, low-cost screening of valvular heart disease
Doctor V. Pergola (Naples, IT)
Presentation thumbnail
Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study
Doctor B. Hrymniak (Wroclaw, PL)
Abstract
Presentation thumbnail
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Doctor Y. Shhab (Bucharest, RO)
Abstract
Presentation thumbnail
Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort
Ms A. Bondoc (Timisoara, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Relevance of systematic multipolar remapping after ventricular tachycardia substrate ablation
thumbnail
Congress Presentation
Peak frequency and local conduction velocity dynamics within ventricular scar: mechanistic insights and substrate homogenisation after ablation
thumbnail
Congress Session
Pushing boundaries: recent innovations in ventricular arrhythmia ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources